Renaissance Technologies’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$729K Buy
31,234
+1,724
+6% +$40.2K ﹤0.01% 2657
2025
Q1
$449K Sell
29,510
-1,833
-6% -$27.9K ﹤0.01% 2786
2024
Q4
$575K Buy
31,343
+539
+2% +$9.9K ﹤0.01% 2780
2024
Q3
$342K Buy
30,804
+1,200
+4% +$13.3K ﹤0.01% 2934
2024
Q2
$275K Sell
29,604
-7,409
-20% -$68.8K ﹤0.01% 2940
2024
Q1
$1.21M Buy
37,013
+17,651
+91% +$578K ﹤0.01% 2365
2023
Q4
$518K Buy
19,362
+10,698
+123% +$286K ﹤0.01% 2752
2023
Q3
$524K Sell
8,664
-3,393
-28% -$205K ﹤0.01% 2688
2023
Q2
$1.23M Buy
12,057
+11,069
+1,120% +$1.13M ﹤0.01% 2339
2023
Q1
$175K Buy
+988
New +$175K ﹤0.01% 3332
2022
Q2
Sell
-4,421
Closed -$1.93M 4637
2022
Q1
$1.93M Sell
4,421
-5,605
-56% -$2.45M ﹤0.01% 2256
2021
Q4
$4.4M Buy
+10,026
New +$4.4M 0.01% 1620
2021
Q3
Sell
-4,346
Closed -$2.23M 3925
2021
Q2
$2.23M Sell
4,346
-2,917
-40% -$1.5M ﹤0.01% 2186
2021
Q1
$5.68M Sell
7,263
-479
-6% -$374K 0.01% 1571
2020
Q4
$4.22M Sell
7,742
-563
-7% -$307K ﹤0.01% 1700
2020
Q3
$3.8M Buy
8,305
+5,837
+237% +$2.67M ﹤0.01% 1737
2020
Q2
$1.52M Buy
+2,468
New +$1.52M ﹤0.01% 2333
2019
Q1
Sell
-11,476
Closed -$5.37M 3749
2018
Q4
$5.37M Buy
+11,476
New +$5.37M 0.01% 1684
2016
Q4
Sell
-6,886
Closed -$2.07M 3499
2016
Q3
$2.07M Buy
+6,886
New +$2.07M ﹤0.01% 2164
2016
Q2
Sell
-2,483
Closed -$556K 3542
2016
Q1
$556K Buy
2,483
+1,162
+88% +$260K ﹤0.01% 2819
2015
Q4
$802K Sell
1,321
-5,668
-81% -$3.44M ﹤0.01% 2562
2015
Q3
$3.6M Buy
6,989
+1,187
+20% +$611K 0.01% 1612
2015
Q2
$2.54M Sell
5,802
-1,776
-23% -$777K 0.01% 1910
2015
Q1
$2.74M Buy
7,578
+6,914
+1,041% +$2.5M 0.01% 1743
2014
Q4
$238K Buy
+664
New +$238K ﹤0.01% 2645